9 ms·

It is an emergency authorization vaccine. We haven't had the full trials. No one can honestly claim these are safe long term. In fact, they don't. The manufactu

It is an emergency authorization vaccine. We haven't had the full trials. No one can honestly claim these are safe long term. In fact, they don't. The manufacturers do not assume any liability for you choosing to consume their experimental product. https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-compensation-lawsuit.html https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-c...

greg5green 5y ago
If you're in the US, this is one of the dumbest reasons to use against COVID-19 vaccines, since all vaccines have had the same treatment since 1986 via the National Childhood Vaccine Injury Act.
- chitowneats 5y ago
  The article I linked discusses the National Vaccine Injury Compensation Program at length. Would you care to discuss the claim in the article that this program has paid very few claims in the decades since it was created? I checked: it is the exact program created by the National Childhood Vaccine Injury Act of 1986. We're talking about the same thing. tl;dr: the pharma companies don't have to pay you and the government is extremely unlikely to.
bawolff 5y ago
That depends a bit on your country.
- chitowneats 5y ago
  Assuming you live in the West, we are all taking the same few vaccines. The trials are not complete for any of the big 3. The specifics of the legality vary from country to country. It typically takes nearly a decade to approve a new vaccine.
  - doktorhladnjak 5y ago
    A major portion of that typical 10 year approval process is running a clinical trial where enough people get sick to have statistically significant results. When the trials for all the EUA vaccines were run last year, COVID was extremely widespread. That dramatically shortened how long trials needed to run to prove effectiveness.
    - chitowneats 5y ago
      If the trials were comprehensive enough to prove both efficacy and safety, why did they not catch the AZ & JnJ blood clotting issues? One theory is that these problems primarily afflict those under 40 and this population was not adequately represented in the clinical trials.
      - bawolff 5y ago
        Blood clots happen at a rate of something like 1 in 100,000 people, the trial had something like 20,000 people getting the vaccine in it. Statistically its not surprising it wasn't caught. That the risk is probably not equally distributed just furthers that. For the trial to pick up the blood clots, it would probably have to administer the vaccine to at least half a million people if not more (and you would need other people for the placebo arm). If the size of your trial is a significant portion of a medium sized country, you are not really running a trial but just giving out a vaccine. The trial established it works, and any safety concerns are rare enough that the risk of not just getting covid but getting covid and having severe illness or dying from covid, is higher for most people. There is no 100% garuntees in life, the best we can hope for is showing that the risk is less than the alternative.
        chitowneats 5y ago
        Many of us have preexisting immunity. For that population, the marginal benefit of vaccination is zero. People should be informed about the risks.

greg5green 5y ago

If you're in the US, this is one of the dumbest reasons to use against COVID-19 vaccines, since all vaccines have had the same treatment since 1986 via the National Childhood Vaccine Injury Act.

chitowneats 5y ago
The article I linked discusses the National Vaccine Injury Compensation Program at length. Would you care to discuss the claim in the article that this program has paid very few claims in the decades since it was created? I checked: it is the exact program created by the National Childhood Vaccine Injury Act of 1986. We're talking about the same thing. tl;dr: the pharma companies don't have to pay you and the government is extremely unlikely to.

bawolff 5y ago

That depends a bit on your country.

chitowneats 5y ago
Assuming you live in the West, we are all taking the same few vaccines. The trials are not complete for any of the big 3. The specifics of the legality vary from country to country. It typically takes nearly a decade to approve a new vaccine.
- doktorhladnjak 5y ago
  A major portion of that typical 10 year approval process is running a clinical trial where enough people get sick to have statistically significant results. When the trials for all the EUA vaccines were run last year, COVID was extremely widespread. That dramatically shortened how long trials needed to run to prove effectiveness.
  - chitowneats 5y ago
    If the trials were comprehensive enough to prove both efficacy and safety, why did they not catch the AZ & JnJ blood clotting issues? One theory is that these problems primarily afflict those under 40 and this population was not adequately represented in the clinical trials.
    - bawolff 5y ago
      Blood clots happen at a rate of something like 1 in 100,000 people, the trial had something like 20,000 people getting the vaccine in it. Statistically its not surprising it wasn't caught. That the risk is probably not equally distributed just furthers that. For the trial to pick up the blood clots, it would probably have to administer the vaccine to at least half a million people if not more (and you would need other people for the placebo arm). If the size of your trial is a significant portion of a medium sized country, you are not really running a trial but just giving out a vaccine. The trial established it works, and any safety concerns are rare enough that the risk of not just getting covid but getting covid and having severe illness or dying from covid, is higher for most people. There is no 100% garuntees in life, the best we can hope for is showing that the risk is less than the alternative.
      - chitowneats 5y ago
        Many of us have preexisting immunity. For that population, the marginal benefit of vaccination is zero. People should be informed about the risks.